Embryofetopathy due to oral anticoagulant therapy

ICD-11 code : LD2F.02;

Preferred Label : Embryofetopathy due to oral anticoagulant therapy;

ICD-11 definition : A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.;

ICD-11 inclusion : Vitamin K antagonists embryofetopathy; dysmorphism due to warfarin; Coumarin embryopathy; Fetal warfarin syndrome;

Details

Origin ID

71579696;

UMLS CUI

C0265374;

Currated CISMeF NLP mapping
- Dysmorphism due to warfarin [ICD-10 Sub-category]
- Dysmorphism due to warfarin [ICD-10 Sub-category (who)]
- Fetal Warfarin Syndrome [NCIt concept]
- Fetal warfarin syndrome [MedDRA LLT]
- Fetal warfarin syndrome (disorder) [SNOMED CT concept]
- Foetal warfarin syndrome [MedDRA Preferred Term]
- Vitamin K antagonist embryofetopathy [ORDO Disease]
- Warfarin syndrome [MeSH concept]
- fetal warfarin syndrome [SNOMED Notion]
- warfarin syndrome [MeSH Supplementary Concept]
ICD-10 Mapping
- Dysmorphism due to warfarin [ICD-10 Sub-category]
Semantic type(s)
- Disease or Syndrome [UMLS semantic type]
UMLS correspondences (same concept)
- Dysmorphism due to warfarin [ICD-10 Sub-category]
- Fetal Warfarin Syndrome [NCIt concept]
- Fetal warfarin syndrome [MedDRA LLT]
- Fetal warfarin syndrome (disorder) [SNOMED CT concept]
- Foetal warfarin syndrome [MedDRA Preferred Term]
- Vitamin K antagonist embryofetopathy [ORDO Disease]
- Warfarin syndrome [MeSH concept]
- fetal warfarin syndrome [SNOMED Notion]
- warfarin syndrome [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients